openPR Logo
Press release

Ophthalmic Drugs Market Research Report, Industry Growth, Business Share, Size, Developments, Competitive Landscape Analysis by 2027

01-28-2022 10:38 AM CET | Health & Medicine

Press release from: Market Research Future

/ PR Agency: Market Research Future
“Global Ophthalmic Drugs Market” Report of Market Research Future (MRFR)’s Explores Scope of the Study as Research Objective, Assumptions and Limitations in-depth. The report gives Market Dynamics by Major Drivers, Restraints, Opportunities and Challenges.

Market Scenario

A number of factors such as rising prevalence of eye diseases, growing awareness, huge research funding in ophthalmology, unmet medical needs, rising competition among market players, improving regulatory framework, aging population, and increasing government assistance, are a few factors propelling the growth of the global ophthalmic drugs market. According to the 2017 statistics suggested by the World Health Organization (WHO), the chronic eye disease is the main cause of vision loss, globally.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5753

Owing to the rising cases of eye diseases, the demand for an effective treatment option has also been escalating. In the recent years, various new and existing marketers have come up with effective drugs. For instance, in November 2017, Bausch & Lomb, a U.S.-based company, received the FDA approval for Vyzulta (latanoprostene bunod ophthalmic solution). The drug is designed for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension.

However, the high cost associated with a diagnosis of eye diseases, side effects of available treatment options, and lack of healthcare insurance may hamper the growth of the market.

It is estimated that the Ophthalmic Drugs Market is expected to grow at a CAGR 6.0% during the forecast period of 2017 to 2023.

Segmentation

The global ophthalmic drugs market is segmented on the basis of indication, drug class, type of dosage, product, distribution channel.

On the basis of indication, the market is classified as glaucoma, retinal disorders, inflammation/infection, dry eye, allergies, uveitis, and others.

On the basis of the drug class, the market is classified as antiallergy, anti-VEGF agents, anti-inflammatory, antiglaucoma, and others. The anti-inflammatory class is further segmented into nonsteroidal drugs and steroidal drugs.

On the basis of type of dosage, the market is classified as eye drops, eye solutions, ointments, capsules and tablets, and gels.

On the basis of the product, the market is classified as prescription drugs and OTC drugs.

On the basis of the distribution channel, the market is classified as hospital pharmacies, online pharmacies, drug stores, and others.

Regional Analysis

The Americas dominates the ophthalmic drugs market owing to the presence of patient population, rising prevalence of eye diseases, well-developed technology, high healthcare expenditure, and the presence of the leading players. According to the glaucoma research foundation, in the United States, more than 120,000 are blind because of glaucoma. This accounts for 9 to 12% of all the cases of blindness. It is also reported that over 3 million Americans have glaucoma, but only a few of them know they have it. It is also reported that glaucoma accounts for more than 10 million visits to physicians each year. In November 2017, Bausch & Lomb, a U.S.-based company, received the FDA approval for Vyzulta (latanoprostene bunod ophthalmic solution). The drug is designed for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension. In December 2017, Rhopressa (netarsudil ophthalmic solution) by Aerie Pharmaceuticals has also received the FDA approval for the treatment of glaucoma or ocular hypertension.

Europe holds the second position in the ophthalmic drugs market. It is expected that the government support towards research and development expenditure, increasing competition among marketers, and amendments in reimbursement policies in healthcare are likely to drive the European market.

Asia Pacific is the fastest growing ophthalmic drugs market owing to a huge patient pool, increasing demand, and development in healthcare technology.

The Middle East and Africa hold the lowest share of the global ophthalmic drugs market due to low development, lack of technical knowledge, and poor medical facilities.

Key Players

Some of the key players in the global ophthalmic drugs market are Actavis Generics, Allergan Plc, Bausch & Lomb Inc., Genentech, Inc., Merck & Co., Inc., Pfizer Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Shire Plc, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International, Inc., and others.

Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/ophthalmic-drugs-market-5753

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ophthalmic Drugs Market Research Report, Industry Growth, Business Share, Size, Developments, Competitive Landscape Analysis by 2027 here

News-ID: 2539893 • Views: 132

More Releases from Market Research Future

Feed Acidulants Market: Top Suppliers, Business Development Market and Forecast …
Feed Acidulants Market-Overview The escalation in animal feed demand due to increased livestock rearing is estimated to boost the feed acidulants market. The agriculture reports are made by Market Research Future, which includes market choices for advance. A promising CAGR is estimated to promote the global market in the coming period. The raised intake of animal-based products is predicted to add momentum to the feed acidulants industry share in the forthcoming period.
Consumption of Organically Grown Crops to Benefit Global Biorational Pesticides …
Biorational pesticides are materials which causes minimal to zero harm to humans, animals, and the surrounding environment. These pesticides can contain organisms or formulations derived from biological entities. The global biorational pesticides market report by Market Research Future (MRFR) contains insights on growth enablers, opportunities, restraints, and challenges to be faced by the industry for the period of 2018 to 2023 (forecast period). The outbreak of the COVID-19 virus and
Bicycle Apparels and Accessories Market To Benefit From Healthy Lifestyle Adopti …
Bicycle Apparels & Accessories Market-Overview Increased engagement in outdoor activities and increased knowledge of the benefits of these activities on a child's health have driven the global cycling apparels and accessories market in recent years. According to Market Research Future, the market will gain a CAGR of 5.05% and reach a value of USD 9,529.1 million by 2027. The global bicycle apparels and accessories market grew due to increased participation in outdoor
Are Wireless Phone Chargers the Perfect Alternatives to their Wired Counterparts …
Introduction to Wireless Phone Charging Wireless phone charging is currently all the rage worldwide, given its ability to deliver energy from a single power source to the phone without requiring wires or any connections. The charging station gives out energy, on the other hand, a receiver (in this case, the phone) takes in the energy to charge the battery. To charge phones, wireless charging is one of the most convenient, safe

All 5 Releases


More Releases for Pharmaceutical

Pharmaceutical Packaging Equipment Market
The Global Pharmaceutical Packaging Equipment Market is expected to grow from USD 62235.24 Millions in 2018 to USD 98562.24 Millions by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.78%. Get Free Sample: https://reports.valuates.com/request/sample/360I-Auto-4F48/Global_Pharmaceutical_Packaging_Equipment "Growing pharmaceutical industry in emerging economies is one of the factors largely attributing to the growth of the Global Pharmaceutical Packaging Equipment Market " View Full Report: https://reports.valuates.com/market-reports/360I-Auto-4F48/global-pharmaceutical-packaging The factors attributing to the growth of the
Metronidazole Market by Top Manufacturers – Hongyuan Pharmaceutical, Yinhe Aar …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil Scope of the Report: This report focuses on the Metronidazole in global market, especially in North
Evolving Pharmaceutical Marketing Strategies
Publisher’s latest report,"Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing" provides a comprehensive analysis of the changing pharmaceutical marketing landscape in the digital age. While the pharmaceutical industry readily adopts new technologies to provide medical advancements, it has been much slower to adopt technology within its marketing efforts, mostly relying on traditional channels and methods. However, the decreasing effectiveness of these traditional channels, given changing physician, patient
Vitamin C Market 2017 -CSPC Pharmaceutical Group, DSM, Shandong Luwei Pharmaceut …
Apex Research, recently published a detailed market research study focused on the "Vitamin C Market" across the global, regional and country level. The report provides 360° analysis of "Vitamin C Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Vitamin C industry, and estimates the future trend of Vitamin C market